Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014642

Director sold 39,272 shares at $25.39 ($997,195)

  • Director acquired 39,272 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leonard Keith R · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form 10b5-1 +27,052 $8.63 $233,459 49,175 D
2026-03-02 Exercise or conversion : show line 2 in the form 10b5-1 +12,220 $7.51 $91,772 61,395 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −39,272 $25.39 $997,195 22,123 D
Open-market sales · 39,272 sh · avg $25.39 · $997,195

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −27,052 0 D
2026-03-02 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −12,220 0 D
Loading xslF345X05/wk-form4_1772659056.xml…